Loading…
German maker of glass and plastic packaging and drug-delivery devices such as vials, syringes and bottles for pharma and cosmetics.
German maker of glass and plastic packaging and drug-delivery devices such as vials, syringes and bottles for pharma and cosmetics.
Sells packaging and delivery devices that become part of a medicine's regulatory approval, so once a drug is launched in its vial or syringe, switching is slow. Glass-making is energy-hungry, so furnace running costs weigh on margins, and plants need large, ongoing investment.
In one line: A German, packaging-focused smaller West Pharmaceutical Services.
Moat: narrow (regulatory licence, customer qualification, scale). Pharma-grade manufacturing qualifications create high switching costs, but capital-intensive glass/plastic manufacturing is competitive.
Headquarters: Duesseldorf, Germany · Founded: 1864 · Employees: 13,528
Size Gerresheimer (GXI.DE) is a Germany Materials company (Containers/Packaging) with a market value of $1.21B, the 133rd largest of 205 Germany companies the cockpit tracks. Shares closed at €31.20 on 6 Nov 2026.
Performance Over six months the shares gained 24.1%, against -10.5% for the median peer and +2.6% for the Germany market (cap-weighted) — 4th highest of 21 in its peer set.
Growth Revenue grew 8.9% over the last twelve months (peer median +0.6%); the operating margin is -4.1% (peer median 6.5%).
Valuation It trades at 18.0× forward earnings against a peer median of 17.2× (10th cheapest of 19).
Price implies For today's price to make sense, revenue must grow about 56% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is +45 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 7.2 points below its cost of capital (5.0% WACC).
Next results Next results expected around 25 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | €2.28B | €2.32B | €1.99B | €1.99B | €1.82B |
| Revenue growth | — | +17% | 0% | +10% | — |
| Gross profit | €348M | €495M | €502M | €551M | €500M |
| EBITDA | €434M | €377M | €358M | €396M | €350M |
| Net income | -€401M | -€320M | €82.3M | €116M | €96.1M |
| Free cash flow | €7.88M | -€98.8M | -€130M | -€33.4M | -€15.9M |
| Capital expenditure | €254M | €308M | €370M | €328M | €238M |
| Total debt | €2.21B | €2.18B | €1.28B | €1.05B | €1.23B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Gerresheimer GXI.DE | $1.21B | +24% | +9% | -4% | 18.0× | 55.8% |
| West Pharmaceutical Services WST | $27.9B | +23% | +13% | 23% | 39.8× | 25.2% |
| SCHOTT Pharma AG & Co. KGaA 1SXP.DE | $3.67B | +31% | +4% | 15% | 22.1× | 11.7% |
| Corning GLW | $91.4B | -43% | +19% | 17% | 25.4× | 24.7% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | GXI.DE | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +9.8% | -6.3% | 2nd highest of 21 |
| 6-month return | +24.1% | -10.5% | 4th highest of 21 |
| Distance from 52-week high | -8.8% | -38.8% | 2nd highest of 21 |
| Revenue growth (TTM) | +8.9% | +0.6% | 5th highest of 21 |
| Operating margin | -4.1% | 6.5% | 2nd lowest of 21 |
| Forward P/E | 18.0× | 17.2× | 10th cheapest of 19 |
| Growth the price implies (Req g, 7 yrs) | 55.8% | 5.7% | most demanding of 11 |
| Growth delivered (Del g) | +10.3% | +5.2% | highest of 11 |
| Hurdle (Req g minus delivered) | +45.4 pp | +2.5 pp | most demanding of 11 |
| ROIC minus cost of capital | -7.2 pp | -0.6 pp | 3rd lowest of 21 |
| EV / EBITDA | 7.2× | 7.1× | 4th most expensive of 8 |
| Net debt / EBITDA | 4.7× | 1.6× | most indebted of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Gerresheimer GXI.DE | Germany | $1.21B | +24% | +9% | -4% | 18.0× | 55.8% | +10.3% |
| Shenzhen Changhong Technology 300151.SZ | China | $1.23B | -12% | -1% | 6% | 59.9× | n/a | n/a |
| Fuji Seal International 7864.T | Japan | $1.18B | +38% | +4% | 9% | 10.8× | -9.5% | +5.9% |
| Shenzhen Leaguer 002243.SZ | China | $1.27B | -18% | +5% | -3% | 19.9× | 44.6% | +1.6% |
| Cascades CAS.TO | Canada | $1.15B | +49% | +1% | 5% | 9.2× | -1.9% | +3.1% |
| Suzhou Hycan 002787.SZ | China | $1.09B | -10% | 0% | 7% | 36.4× | n/a | n/a |
| Orora ORA.AX | Australia | $1.34B | +17% | +6% | 11% | 15.8× | 2.5% | -8.9% |
| Taiwan Hon Chuan Enterprise 9939.TW | Taiwan | $1.07B | +7% | 0% | 15% | 10.2× | n/a | n/a |
| TriMas TRS | United States | $1.37B | -10% | -33% | 5% | 19.1× | n/a | n/a |
| Huangshan Novel 002014.SZ | China | $1.02B | +5% | +9% | 12% | 15.7× | n/a | n/a |
| Elopak ELO.OL | Norway | $1.01B | -11% | 0% | 9% | 11.8× | -8.3% | +7.7% |
| Zhejiang Great Shengda Packing 603687.SS | China | $995M | -30% | +1% | 3% | 32.6× | n/a | n/a |
| Zhejiang Zhongxin Environmental Protection Technology 603091.SS | China | $991M | -20% | +31% | 22% | 14.5× | 7.8% | +4.4% |
| Shanghai Shunho New Materials Technology 002565.SZ | China | $1.51B | -50% | -15% | -3% | n/a | n/a | n/a |
| Xiamen Jihong 002803.SZ | China | $956M | -16% | +12% | 6% | 21.3× | 6.4% | +8.8% |
| Jiangsu Hualan New Pharmaceutical Material 301093.SZ | China | $1.53B | -27% | +6% | 5% | 77.4× | 50.9% | +6.7% |
| Shanghai Zijiang Enterprise 600210.SS | China | $1.54B | -3% | -18% | 10% | 11.3× | n/a | n/a |
| Jiamei Food Packaging (Chuzhou) 002969.SZ | China | $1.55B | -56% | -10% | 6% | 86.4× | 22.4% | +7.3% |
| MYS 002303.SZ | China | $909M | +26% | +1% | 8% | 18.6× | 4.9% | +3.4% |
| Guangzhou Fangbang Electronics 688020.SS | China | $900M | -51% | -2% | -28% | n/a | n/a | n/a |
| Time Technoplast TIMETECHNO.NS | India | $891M | -9% | +16% | 11% | 11.0× | n/a | n/a |